CARDIAC BETA-ADRENOCEPTORS AND ADENYLYL-CYCLASE ACTIVITY IN HUMAN LEFT-VENTRICULAR HYPERTROPHY DUE TO PRESSURE-OVERLOAD

被引:8
作者
GALINIER, M
SENARD, JM
VALET, P
ARIAS, A
DAVIAUD, D
GLOCK, Y
BOUNHOURE, JP
MONTASTRUC, JL
机构
[1] CHU RANGUEIL, SERV CARDIOL & CHIRURG CARDIOVASC, F-31054 TOULOUSE, FRANCE
[2] FAC MED TOULOUSE, INSERM, U317, PHARMACOL MED & CLIN LAB, F-31073 TOULOUSE, FRANCE
关键词
LEFT VENTRICULAR HYPERTROPHY; HUMAN PRESSURE OVERLOAD; BETA-ADRENOCEPTORS; ADENYLYLCYCLASE; ADP-PERTUSSIS TOXIN RIBOSYLATED PROTEINS;
D O I
10.1111/j.1472-8206.1994.tb00784.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of left ventricular hypertrophy (LVH) due to chronic pressure overload on right atrial (RA) and left ventricular (LV) myocardial beta-adrenergic receptor (PAR) density and subtypes, adenylyl cyclase (AC) activity and ADP-pertussis toxin ribosylated proteins was investigated in humans with LVH due to aortic stenosis and in patients without LVH undergoing heart surgery for mitral stenosis or coronary artery disease taken as controls. Both groups presented normal systolic function or plasma catecholamine levels. In LVH and controls, P-AR density was similar in RA (62 +/- 6 vs 77 +/- 12 fmol.mg(-1) protein) and LV (39 +/- 7 vs 32 +/- 2 fmol.mg(-1) protein). In LVH, beta(1)-AR percentage was < than in controls in LV (35 +/- 11 vs 73 +/- 5%, P < 0.05) but not in RA (79 +/- 5 vs 73 +/- 8%). Basal AC activity in RA (19 +/- 4 vs 21 +/- 6 pmol.mg(-1) protein) and LV (22 +/- 5 vs 27 +/- 3 pmol.mg(-1) protein) was similar in LVH and in controls. Isoprenaline-induced stimulation of AC in RA was similar in LVH and in controls (51 +/- 18 vs 36 +/- 18%) but < in LV of LVH (7 +/- 6 vs 45 +/- 6%, P < 0.05). In the presence of ICI-118,551 (a beta(2)-adrenoceptor antagonist), isoprenaline failed to induce any increase in cAMP in LVH. The quantification of ADP-pertussis toxin ribosylated proteins indicated a lower concentration of substrates in LV myocardial membranes from LVH. These data indicate that in LVH due to pressure overload, there is a down-regulation of beta 1-AR and an increase in beta(2)-AR density. This is associated with alterations of the transmembrane signalling marked by a decreased capacity of isoprenaline to stimulate AC and an impaired expression of Gi proteins.
引用
收藏
页码:90 / 99
页数:10
相关论文
共 46 条
[1]  
AGABITIROSEI E, 1985, J AM COLL CARDIOL, V5, P415
[2]   BETA-RECEPTORS AND CONTRACTILE RESERVE IN LEFT-VENTRICULAR HYPERTROPHY [J].
AYOBE, MH ;
TARAZI, RC .
HYPERTENSION, 1983, 5 (02) :I192-I197
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
BRISTOW MR, 1989, MOL PHARMACOL, V35, P295
[5]   DIFFERENCES IN BETA-ADRENERGIC NEUROEFFECTOR MECHANISMS IN ISCHEMIC VERSUS IDIOPATHIC DILATED CARDIOMYOPATHY [J].
BRISTOW, MR ;
ANDERSON, FL ;
PORT, JD ;
SKERL, L ;
HERSHBERGER, RE ;
LARRABEE, P ;
OCONNELL, JB ;
RENLUND, DG ;
VOLKMAN, K ;
MURRAY, J ;
FELDMAN, AM .
CIRCULATION, 1991, 84 (03) :1024-1039
[6]   DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[7]  
BRODDE OE, 1984, J CARDIOVASC PHARM, V6, P1184
[8]   MYOCARDIAL BETA-ADRENOCEPTOR CHANGES IN HEART-FAILURE - CONCOMITANT REDUCTION IN BETA-1-ADRENOCEPTOR AND BETA-2-ADRENOCEPTOR FUNCTION RELATED TO THE DEGREE OF HEART-FAILURE IN PATIENTS WITH MITRAL-VALVE DISEASE [J].
BRODDE, OE ;
ZERKOWSKI, HR ;
DOETSCH, N ;
MOTOMURA, S ;
KHAMSSI, M ;
MICHEL, MC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (02) :323-331
[9]   REGIONAL DISTRIBUTION OF BETA-ADRENOCEPTORS IN THE HUMAN-HEART - COEXISTENCE OF FUNCTIONAL BETA-1-ADRENOCEPTOR AND BETA-2-ADRENOCEPTOR IN BOTH ATRIA AND VENTRICLES IN SEVERE CONGESTIVE CARDIOMYOPATHY [J].
BRODDE, OE ;
SCHULER, S ;
KRETSCH, R ;
BRINKMANN, M ;
BORST, HG ;
HETZER, R ;
REIDEMEISTER, JC ;
WARNECKE, H ;
ZERKOWSKI, HR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (06) :1235-1242
[10]   DRUG-INDUCED AND DISEASE-INDUCED CHANGES OF HUMAN CARDIAC BETA-1-ADRENOCEPTOR AND BETA-2-ADRENOCEPTOR [J].
BRODDE, OE ;
ZERKOWSKI, HR ;
BORST, HG ;
MAIER, W ;
MICHEL, MC .
EUROPEAN HEART JOURNAL, 1989, 10 :38-44